https://www.selleckchem.com/pr....oducts/netarsudil-ar
Majority of the respondents used biologics in less than 2 cases per month. Secukinumab was the most common biologic used followed by etanercept. The factors which determined choice of biologics were convenience, cost, previous experience, co-morbid conditions and recommendations by an expert. A small sample size was the limitation of the study. Dermatologists who do not use biologics may be under-represented in the study. Biologics are not used optimally by Indian dermatologists for management of psoriasis. The cost, fear of
Like
Comment
Share
